Kah Poh Loh1, Chintan Pandya1, Jason Zittel1, Sindhuja Kadambi1, Marie Flannery1,2, Natalie Reizine3, Allison Magnuson1, Giovanna Braganza1, Karen Mustian1, William Dale3, Paul Duberstein1, Supriya Gupta Mohile4,5. 1. James P Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. 2. School of Nursing, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. 3. Department of Medicine, Section of Geriatrics & Palliative Medicine, University of Chicago Medical Center, Chicago, IL, USA. 4. James P Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. supriya_mohile@urmc.rochester.edu. 5. James P. Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Box 704, Rochester, NY, 14642, USA. supriya_mohile@urmc.rochester.edu.
Abstract
PURPOSE: Although sleep disturbances are common in older adults, studies evaluating the prevalence of sleep disturbance and its influence on functional outcomes in older adults with cancer are few. In this study, we examined the prevalence of sleep disturbance and its association with physical function and cognition in older adults with cancer. METHODS: This is a cross-sectional study of patients who were referred and evaluated in the Specialized Oncology Care & Research in the Elderly (SOCARE) clinics at the Universities of Rochester and Chicago from May 2011 to October 2015. All patients underwent a geriatric assessment (GA) as part of their routine evaluation. Our final study cohort included patients who completed a sleep assessment and consented to the study. We collected demographics (age, sex, race, marital status, and education level) and clinical characteristics (depression, comorbidity, cancer type, and stage) from the GA and medical chart reviews. Presence of sleep disturbance was self-reported (yes/no). Physical function was assessed using Instrumental Activities of Daily Living (IADLs), physical activity (PA) survey, falls in the preceding 6 months, and Short Physical Performance Battery (SPPB). Cognition was screened using the Blessed Orientation-Memory-Concentration Test (impairment >4) or Montreal Cognitive Assessment (impairment <26). Bivariate and multivariable analyses were used to examine the associations between sleep disturbance with functional outcomes and cognition. RESULTS: We included 389 older patients. The prevalence of sleep disturbance was 40%. Sixty-eight percent had ≥1 IADL impairment, 76% had PA limitation, 37% had ≥1 fall, 70% had impairment on SPPB, and 47% screened positive for cognitive impairment. On bivariate analyses, sleep disturbance was associated with IADL impairment (odds ratio [OR] 1.96, 95% confidence interval [CI] 1.23-3.13, P = 0.005), and PA limitation (OR 2.43, 95% CI 1.38-4.28, P = 0.002). The associations remained significant on multivariable analyses. Sleep disturbance was not significantly associated with falls, impairment on SPPB, and performance on the cognitive screen. CONCLUSION: Sleep disturbance was associated with IADL impairment and PA limitation. It is important for oncologists to inquire about sleep problems, and these patients should also be screened for functional impairment if sleep disturbance was present.
PURPOSE: Although sleep disturbances are common in older adults, studies evaluating the prevalence of sleep disturbance and its influence on functional outcomes in older adults with cancer are few. In this study, we examined the prevalence of sleep disturbance and its association with physical function and cognition in older adults with cancer. METHODS: This is a cross-sectional study of patients who were referred and evaluated in the Specialized Oncology Care & Research in the Elderly (SOCARE) clinics at the Universities of Rochester and Chicago from May 2011 to October 2015. All patients underwent a geriatric assessment (GA) as part of their routine evaluation. Our final study cohort included patients who completed a sleep assessment and consented to the study. We collected demographics (age, sex, race, marital status, and education level) and clinical characteristics (depression, comorbidity, cancer type, and stage) from the GA and medical chart reviews. Presence of sleep disturbance was self-reported (yes/no). Physical function was assessed using Instrumental Activities of Daily Living (IADLs), physical activity (PA) survey, falls in the preceding 6 months, and Short Physical Performance Battery (SPPB). Cognition was screened using the Blessed Orientation-Memory-Concentration Test (impairment >4) or Montreal Cognitive Assessment (impairment <26). Bivariate and multivariable analyses were used to examine the associations between sleep disturbance with functional outcomes and cognition. RESULTS: We included 389 older patients. The prevalence of sleep disturbance was 40%. Sixty-eight percent had ≥1 IADL impairment, 76% had PA limitation, 37% had ≥1 fall, 70% had impairment on SPPB, and 47% screened positive for cognitive impairment. On bivariate analyses, sleep disturbance was associated with IADL impairment (odds ratio [OR] 1.96, 95% confidence interval [CI] 1.23-3.13, P = 0.005), and PA limitation (OR 2.43, 95% CI 1.38-4.28, P = 0.002). The associations remained significant on multivariable analyses. Sleep disturbance was not significantly associated with falls, impairment on SPPB, and performance on the cognitive screen. CONCLUSION:Sleep disturbance was associated with IADL impairment and PA limitation. It is important for oncologists to inquire about sleep problems, and these patients should also be screened for functional impairment if sleep disturbance was present.
Authors: Arti Hurria; Kayo Togawa; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; Smita Bhatia; Vani Katheria; Shira Klapper; Kurt Hansen; Rupal Ramani; Mark Lachs; F Lennie Wong; William P Tew Journal: J Clin Oncol Date: 2011-08-01 Impact factor: 44.544
Authors: Leslie Y Chiang; Jingxia Liu; Kellie L Flood; Maria B Carroll; Jay F Piccirillo; Susan Stark; Adam Wang; Tanya M Wildes Journal: J Geriatr Oncol Date: 2015-05-11 Impact factor: 3.599
Authors: Roland J Thorpe; Alyssa A Gamaldo; Rachel E Salas; Charlene E Gamaldo; Keith E Whitfield Journal: J Clin Sleep Med Date: 2016-10-15 Impact factor: 4.062
Authors: Nathan A Berger; Panos Savvides; Siran M Koroukian; Eva F Kahana; Gary T Deimling; Julia H Rose; Karen F Bowman; Robert H Miller Journal: Trans Am Clin Climatol Assoc Date: 2006
Authors: Kah Poh Loh; Janet A Tooze; Barbara J Nicklas; Stephen B Kritchevsky; Jeff D Williamson; Leslie R Ellis; Bayard L Powell; Timothy S Pardee; Neha G Goyal; Heidi D Klepin Journal: J Geriatr Oncol Date: 2019-04-05 Impact factor: 3.599
Authors: Reena V Jayani; Allison M Magnuson; Can-Lan Sun; Huiyan Ma; William P Tew; Supriya G Mohile; Ajeet Gajra; Heidi D Klepin; Cary P Gross; Hyman B Muss; Andrew E Chapman; Vani Katheria; Arti Hurria; William Dale Journal: J Geriatr Oncol Date: 2019-12-06 Impact factor: 3.599
Authors: Inger Utne; Borghild Løyland; Ellen Karine Grov; Steven Paul; Melisa L Wong; Yvette P Conley; Bruce A Cooper; Jon D Levine; Christine Miaskowski Journal: Eur J Oncol Nurs Date: 2019-07-02 Impact factor: 2.398
Authors: T M Wildes; S Alibhai; S Sattar; K Haase; S Kuster; M Puts; S Spoelstra; C Bradley Journal: Support Care Cancer Date: 2020-07-16 Impact factor: 3.603
Authors: Rina S Fox; Sharon H Baik; Heather McGinty; Sofia F Garcia; Kathryn J Reid; Katrin Bovbjerg; Precilla Fajardo; Lisa M Wu; Shohreh Shahabi; Jason C Ong; Phyllis C Zee; Frank J Penedo Journal: Int J Behav Med Date: 2021-02